Cargando…

Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17

SIMPLE SUMMARY: The tau protein normally functions to maintain the stability of microtubules, the cellular cytoskeleton that provides structure and shape to eukaryotic cells. Tau protein malfunction is a core feature of a group of neurodegenerative diseases labeled ‘tauopathies’ that include, among...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Dam, Debby, Valkenburg, Femke, Van Kolen, Kristof, Pintelon, Isabel, Timmermans, Jean-Pierre, De Deyn, Peter Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608666/ https://www.ncbi.nlm.nih.gov/pubmed/37895469 http://dx.doi.org/10.3390/life13102088

Ejemplares similares

Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants
por: Kimura, Taeko, et al.
Publicado: (2016)

Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau
por: Zhang, Xue, et al.
Publicado: (2006)

Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
por: Rodriguez-Martin, Teresa, et al.
Publicado: (2009)

The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells
por: Di Primio, Cristina, et al.
Publicado: (2017)

Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils
por: Marreiro, André, et al.
Publicado: (2020)

Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
por: Wszolek, Zbigniew K, et al.
Publicado: (2006)

Transcriptional Signatures of Tau and Amyloid Neuropathology
por: Castanho, Isabel, et al.
Publicado: (2020)

$\beta$ -delayed p and $\gamma$ decay of $^{58}Zn$ and comparison with $^{58}Ni(^{3}He, t)^{58}Cu$ reaction
por: Jokinen, A
Publicado: (2003)

Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes
por: Verheyen, An, et al.
Publicado: (2018)

Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes
por: Verheyen, An, et al.
Publicado: (2019)

SPSC Meeting 58
por: Königsmann, K C, et al.
Publicado: (2002)

Management Meeting No. 58
por: Reich, K H
Publicado: (1961)

Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy
por: Malcolm, Janice C., et al.
Publicado: (2019)

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
por: Kasuga, Kensaku, et al.
Publicado: (2015)

(18)F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
por: Smith, Ruben, et al.
Publicado: (2016)

Agenda for the 58th Meeting of the Research Board, on 17 June 1982
por: Morrison, Douglas Robert Ogston
Publicado: (1982)

Memorandum for the 58th Meeting of the Research Board, 17 June 1982
por: CERN. Geneva. Research Board, et al.
Publicado: (1982)

Freiburg Neuropathology Case Conference: A 58-year-old Patient with an Asymptomatic Cerebellopontine Angle Mass Lesion
por: Schwabenland, M., et al.
Publicado: (2022)

58th INTC Meeting
Publicado: (2018)

CCM no. 80-02 no. 58
Publicado: (1980)

58th LHCC Meeting
por: CERN. Geneva. LHC Experiments Committee, et al.
Publicado: (2002)

Aspects Operationnels 58 59
por: Boutheon, M
Publicado: (1979)

Health Tract, No. 58: Apples
Publicado: (1865)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
por: Forrest, Shelley L, et al.
Publicado: (2018)

Effects of Resveratrol and Morin on Insoluble Tau in Tau Transgenic Mice
por: Yu, Kwun Chung, et al.
Publicado: (2018)

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
por: Betts, Matthew J., et al.
Publicado: (2018)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
por: Van Dam, Debby, et al.
Publicado: (2016)

Identification and characterization of nuclear and nucleolar localization signals in 58-kDa microspherule protein (MSP58)
por: Yang, Chuan-Pin, et al.
Publicado: (2015)

Decision of the 58th Meeting of the Research Board held on 17 June 1982
por: Schopper, Herwig Franz
Publicado: (1982)

Review of 58 patients with necrotizing fasciitis in the Netherlands
por: van Stigt, Sander F. L., et al.
Publicado: (2016)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma
por: Triana‐Baltzer, Gallen, et al.
Publicado: (2021)

Tijuana 58 : las condiciones socioecómicas de la población trabajadora de Tijuana
por: Stavenhagen, Rodolfo
Publicado: (2014)

CERN Opendays 2019 - PR-58
por: Chrul, Anna, et al.
Publicado: (2019)

Status report of NA58, COMPASS
por: G. Mallot
Publicado: (2003)

58th CMS Collaboration Meeting
Publicado: (2004)

SI Parameter meeting N°58
por: Brianti, G
Publicado: (1972)

Use of ejected beam (S.S. 58)
por: Munday, G L
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_1tp3fik9hd645l3lvsa9931hsr